Aspire Biopharma to Present at Sidoti Virtual Investor Conference

Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP), known for its innovative drug delivery technology, will participate in the Sidoti Virtual Investor Conference on August 20. Kraig Higginson, the Interim CEO, will lead the presentation at 1:45 PM Eastern. The event offers a platform for investors to learn about the company's advancements.

Aspire will also engage in one-on-one virtual meetings with investors on August 20 and 21. Those interested can register for both the presentation and meetings through the Sidoti website. A replay of the presentation will later be accessible via Aspire's investor relations section.